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Abstract
Background: MicroRNAs (miRNAs) are a class of endogenous, small and highly conserved noncoding RNAs that
control gene expression either by degradation of target mRNAs or by inhibition of protein translation. They play
important roles in cancer progression. A single miRNA can provoke a chain reaction and further affect protein
interaction network (PIN). Therefore, we developed a novel integrative approach to identify the functional roles and
the regulated PIN of oncomirs.
Results: We integrated the expression profiles of miRNA and mRNA with the human PIN to reveal miRNA-regulated
PIN in specific biological conditions. The potential functions of miRNAs were determined by functional enrichment
analysis and the activities of miRNA-regulated PINs were evaluated by the co-expression of protein-protein
interactions (PPIs). The function of a specific miRNA, miR-148a, was further examined by clinical data analysis and cell-
based experiments. We uncovered several miRNA-regulated networks which were enriched with functions related to
cancer progression. One miRNA, miR-148a, was identified and its function is to decrease tumor proliferation and
metastasis through its regulated PIN. Furthermore, we found that miR-148a could reduce the invasiveness, migratory
and adhesive activities of gastric tumor cells. Most importantly, elevated miR-148a level in gastric cancer tissues was
strongly correlated with distant metastasis, organ and peritoneal invasion and reduced survival rate.
Conclusions: This study provides a novel method to identify active oncomirs and their potential functions in
gastric cancer progression. The present data suggest that miR-148a could be a potential prognostic biomarker of
gastric cancer and function as a tumor suppressor through repressing the activity of its regulated PIN.
Background
MicroRNAs are small non-coding, single stranded RNA
of ~22 nucleotides in length that are abundantly found in
eukaryotic cells [1]. The complementarity is between
seed regions of mature miRNAs and their target messen-
gers, enabling miRNA-mRNA interactions to occur.
These interactions are crucial for post-transcriptional
regulation of target gene expression by obstructing the
mRNA translation or stability in the cytoplasm, and
depend on both the expression levels of miRNAs and
target mRNAs [2,3]. Some miRNAs are reported as onco-
mirs which could function as either oncogenes or tumor
suppressors [4]. For example, miR-21 decreased tumor
suppressor Pdcd4 expressio na n dp r o m o t e di n v a s i o n ,
intravasation and metastasis in colorectal cancer [5].
MiR-21 also regulated PTEN-dependent pathway and
affected cell growth, migration and invasion of hepatocel-
lular cancer [6]. Moreover, miR-21 and miR-155 were
significantly associated with cancer metastasis and
patients with higher miR-21 or miR-155 expression levels
had worse survival [7]. MiR-155 was found to be up-
regulated during innate immune response and autoim-
m u n ed i s o r d e r sa sw e l la si nv a r i o u sm a l i g n a n c i e s .I n
addition, miR-155 targeted tumor suppressor WEE1
homolog-S. pombe (WEE1) and caused gene alternation
required for cancer development and progression [8]. On
the other hand, let-7 decreased cell proliferation and
migration of glioblastoma and reduced tumor size in
xenograft model [9]. Let-7 prevented early cancer pro-
gression through suppressing embryonic gene high mobi-
lity group, A2 (HMGA2) expression [10]. Metastatic
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any medium, provided the original work is properly cited.gastric cancer cells secreted let-7 via exosomes into the
extracellular environment to maintain their oncogenesis
[11].
Recently, many reports showed that they successfully
identified miRNA targets using miRNA expression pro-
files [12,13]. Huang et al. used RNA expression data to
identify 1597 high-confidence target predictions for 104
human miRNAs and further verified let-7b was down-
regulated in retinoblastoma and CDC25A and BCL7A
were targets of let-7b using qRT-PCR and microarray
profile. Li et al. combined sequence complementarity,
miRNA expression level, and protein abundance to iden-
tify miRNA targets for elevating their predictions. They
also found that translational repression of targets by miR-
NAs was dominant mechanism in miRNA regulation.
Moreover, sequence-based computational methods have
been broadly used to predict putative miRNA targets
[14], and can reach pretty good prediction rate, including
cancer-related miRNAs [15,16]. Previous report has also
indicated that computational prediction should take into
account the expression profiles of both miRNA and
mRNA [3]. Therefore, the development of an integrative
approach that incorporated expression data to facilitate
the identification of condition-specific targets of miRNAs
becomes increasingly important.
MicroRNA can obstruct the translation of mRNA,
thereby directly affecting protein abundance [15,16] and
PINs [17,18]. For example, Yu et al. analyzed correlations
between transcription factors (TFs) and miRNAs and
further discovered that different regulatory networks
formed by miRNA and TFs were involved in different
biological functions [17]. Additionally, Liang et al. found
global correlation between miRNA repression and pro-
tein-protein interactions and elucidated the related biolo-
gical processes of miRNA-regulated PINs [18]. PINs are
sets of interactions formed by two physically interacting
proteins, which are fundamental to most biological pro-
cesses [19]. With the accumulation of PPI data, it is
becoming increasingly possible to understand the archi-
tecture and function of the cellular network by computa-
tional approaches [20,21]. Recently, we characterized the
global properties of miRNA regulation in human PIN
and proposed possible mechanisms of how these miR-
NAs regulate PINs [22]. Additionally, previous studies
have demonstrated that miRNAs can affect specific biolo-
gical functions which are involved in tumorigenesis and
cancer progression through the regulation of a small
number of genes within biological networks, such as
PINs [23,24]. Thus, assessing how miRNAs affect PINs
could facilitate the discovery of potential miRNA-related
networks and allow the characterization of associated
biological functions.
In this study, we proposed an integrative analysis
which suggested that miRNA-regulated PINs could be
identified based on the combination of down-regulated
miRNAs and up-regulated mRNAs. The procedure for
miRNA-regulated PIN identification and analysis is illu-
strated in Figure 1. We subsequently showed that the
networks that were modulated by these down-regulated
miRNAs in tumors tended to be activated in gastric can-
cer. Among these was the miR-148a-regulated PIN,
which was involved in metastasis-related biological pro-
cesses that were associated with tumor suppression. In
particular, miR-148a was shown to inhibit tumor inva-
sion, migration, adhesion and cell growth, and pro-
longed patient survival. These findings suggest that
miR-148a is not only a potential prognostic marker that
can be used for the detection of human gastric cancer,
but it can also suppress gastric cancer progression
through the regulation of its associated network.
Results
MicroRNA-regulated PINs in Gastric Cancer
Although microRNAs are known to reduce the levels of
their target mRNAs [25], expression of a miRNA target
may not always co-vary, in the reverse direction, with its
miRNA regulator, due to the presence of primary TF reg-
ulation. A reverse correlation in expression profiles
between a miRNA and corresponding predicted targets
increases the confidence of the conditional miRNA-target
interaction (See Additional file 1). Based on these obser-
vations, we combined differentially expressed miRNAs
and target genes, down-regulated (up-regulated) miRNAs
versus up-regulated (down-regulated) targets, to identify
the miRNA-regulated PINs in gastric cancer. The
miRNA-regulated PINs were established according to the
proteins encoded by differentially expressed target genes
and their interacting partners in the human PIN. How-
ever, only 23 significantly down-regulated miRNAs and
no significantly up-regulated miRNAs were found (see
Methods in Additional file 1). Consequently, we identi-
fied 23 PINs that were modulated by 23 down-regulated
miRNAs in gastric cancer. Furthermore, the activities of
miRNA-regulated PINs in normal and tumor tissues,
activated or inactivated, were investigated on the basis of
the enrichment of co-expressed PPIs (CePPIs) in the net-
work (Additional file 1, Table S1, S2). Among the 23
down-regulated miRNA-regulated PINs, 70% (16/23) of
them were activated in tumors (Fisher’se x a c tt e s t ,P <
0.001). On the other hand, 51% (20/39) of the remaining
39 unchanged miRNA-regulated PINs were inactivated in
both tumor and normal tissue (Fisher’s exact test, P =
0.003). Considering that HPRD PIN was incomplete, we
randomly removed some proportions of PPIs, from 5%
(1744 PPIs) to 20% (6974 PPIs), and evaluated the effects
on the activities of miRNA-regulated networks. Most of
the miRNAs remained activated in tumor (~75%) with
1000 repeated random removal tests (Additional file 1,
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missing PPIs. Thus, we conclude that 16/23 networks are
activated in gastric cancer and that these networks are
modulated as a result of down-regulated miRNAs expres-
sion. Therefore, we suggest that the 16 down-regulated
miRNAs act as oncomirs and function as tumor
suppressors.
Additionally, we assessed the discrimination power of
miRNA expression levels to classify normal and tumor
samples by calculating the receiver operating characteristic
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Figure 1 Expression profiles of miRNAs and genes were used to discover condition-specific targets of miRNAs. The miRNA-regulated
PINs were denoted as the PIN which is formed by their differentially expressed targets (L0) and interacting partners (L1). The enrichment of
CePPIs involved in the miRNA-regulated PIN was utilized to evaluate the activity of the network. The potential miRNA-regulated functions were
predicted by functional enrichment analysis.
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Among the 23 down-regulated miRNAs, the one that pro-
vided the best discrimination was miR-29c (AUC = 0.831,
P < 0.001), which gave an overall correct classification of
77%. Moreover, of the 16 oncomirs, miR-29c, miR-768-3p,
miR-26a, miR-143 and miR-148a were found to give an
AUC of more than 0.7 (P < 0.05) individually. When all
the 16 oncomirs were combined, the overall correct classi-
fication was elevated to 93% (AUC = 0.981, P < 0.0001).
Among the remaining 7 down-regulated miRNAs, only
miR-16 and miR-145 were found to have an AUC of more
than 0.7. When these 7 miRNAs combined, the overall
correct classification was 82% (AUC = 0.888, P < 0.0001)
(Additional file 1, Table S3). Taken together, the 16 onco-
mirs showed greater discrimination between tumor and
normal tissues than the remaining 7 down-regulated
miRNAs.
We also investigated the relationship between the
expression levels of the 23 down-regulated miRNAs and
survival rates. The median was used as a cut-off value
and as a result, the expression levels for each miRNA
were divided into two groups; high and low expressed.
T h em a x i m u mo ft h ed i f f e r e n c ei ns u r v i v a lr a t e s( D max)
between high and low groups was further calculated
(Additional file 1, Figure S2A). Our findings indicated
that the Dmax among the 16 oncomirs was more signifi-
cant (P < 0.0001, Additional file 1, Figure S2B) than that
in the remaining 7 down-regulated miRNAs (paired
Wilcoxon rank sum test, P = 0.016, Additional file 1,
Figure S2C). These results suggest that the 16 oncomirs
may act as better prognostic markers for gastric cancer
in comparison to the remaining 7 down-regulated miR-
NAs. Therefore, we conclude that the 16 oncomirs have
the potential to suppress tumor biogenesis.
The Potential Functions of Oncomir-regulated PINs
A key question is whether the 16 oncomirs regulate
tumor progression-related biological processes in gastric
cancer. To address this, we developed a PIN-based
approach to reveal the possible functional roles of miR-
NAs (see Methods in Additional file 1). Our findings
showed that union of miRNA-regulated targets (L0) and
their interacting partners (L1) displayed the most
enriched GO functional terms and trees on average
(Additional File 1, Table S4). The low coverage of L0
genes (<50%) (Additional File 1, Table S4), indicated that
the functional relationship between L0 genes was weak.
H o w e v e r ,t h eh i g hc o v e r a g eo fu n i o ng e n e s( a p p r o x i -
mately 100%) (Additional File 1, Table S4) suggested that
there was a very strong functional relationship between
these genes. Additionally, our previous analysis on
miRNA regulation in human PIN [22] also suggested that
miRNA-regulated genes and their interacting partners
jointly showed significantly higher modularity than
miRNA-regulated genes alone. Based on these results,
analysis of regulatory mechanisms of miRNAs in the con-
text of the PIN enables a more accurate prediction of the
potential functions of miRNAs.
Applying this PIN-based approach to 16 oncomirs, the
enriched biological processes of their regulated PINs can
be discovered (Additional File 1, Table S5). It was
observed that most of the enriched biological processes
were related to tumor progression. For instance, miR-
142-3p- and miR-768-3p-regulated PINs were related to
apoptosis and cell cycling, respectively. Interestingly, the
miR-148a-regulated PIN was the only network that was
associated with cancer metastasis-related functions, such
as integrin-mediated signaling, cell-matrix adhesion and
wound healing. Therefore, miR-148a was chosen for the
further studies.
MiR-148a-regulated PIN and Its Potential Functions in
Gastric Cancer
To further confirm the abundance of miR-148a in tumor
tissues, we performed qRT-PCR in 62 paired tumor and
normal tissues and found its expression levels in tumor
tissues were significantly lower than those in normal
tissues (P <0 . 0 0 0 1 ,p a i r e dt-test) (Figure 2A), which was
consistent with our miRNA microarray data. Addition-
ally, the impact of miR-148a expression levels on the
prognosis of gastric cancer patients by Kaplan-Meier sur-
vival analyses was studied in the 62 paired tissues.
Patients with high miR-148a expression levels showed
significantly higher 5-year overall survival rates (71.4%,
log-rank test, P = 0.03; Figure 2B) compared with
patients with low miR-148a levels (32.1%, log-rank test,
P = 0.03). Univariate analysis showed that miR-148a and
early stages correlated with better survival, whereas peri-
toneal and vascular invasion predicted very poor out-
comes. On multivariate analysis, miR-148a retained an
independent prognostic power on overall survival (HR =
1.69; P = 0.002) (Additional File 1, Table S6). A ROC
curve was also used to evaluate miR-148a as a diagnostic
marker for gastric cancer. The AUC was then used as an
indicator of the capacity of miR-148a to act as a diagnos-
tic marker, with higher AUC values reflecting a higher
diagnostic potential. ROC curve analysis of miR-148a
showed that it had an AUC of 0.84 (ROC curves analysis,
P = 0.0001, Figure 2C). These results indicate that miR-
148a could discriminate between normal and tumor
tissues and serve as an effective prognostic marker for
gastric cancer. Based on these results, we conclude that
miR-148a is highly associated with gastric cancer. The
miR-148a-regulated PIN was visualized in Figure 2D and
the enriched biological processes of this network are
shown in Figure 2E. The significantly over-represented
GO functional terms were separated into three functional
groups, including cell-matrix adhesion (hypergeometric
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Figure 2 miR-148a and its regulated PIN. (A) miR-148a expression levels (Mean ± standard error) were detected and normalized to U6 snRNA
by qRT-PCR (P < 0.0001, paired t-test). (B) The effect of miR-148a expression levels on patient survival was measured. Cut-off value of 0.101 was
determined based on the finding that miR-148a expression levels in 60% of patients (37 out of 62) that survived for a period of 2 to 140 months
after surgical resection were above 0.101. Solid and dotted lines represent high (≧0.101, N = 50) and low (<0.101, N = 12) miR-148a levels. (C)
The AUC of miR-148a was 0.84 (0.76-0.90, 95% confidence interval) (ROC curves analysis, P = 0.0001). (D) Red nodes represent up-regulated
target genes and blue nodes represent their interacting partners within the human PIN. Green edges represent predicted interactions between
miRNAs and targets and purple edges represent PPIs between proteins. (E) Nodes represent enriched GO terms in the miR-148a-regulated PIN
and edges represent the relationships in the GO. P-value of each enriched GO terms: cell-matrix adhesion: 9.5619E-6, wound healing: 5.8018E-5,
blood coagulation: 8.0094E-4, cell surface receptor linked signal transduction: 5.3054E-5, integrin-mediated signaling pathway: 3.1108E-6, enzyme
linked receptor protein signaling pathway: 2.3001E-4.
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cell surface receptor linked signal transduction (P =
5.3054E-5). These three enriched GO functions suggest
that miR-148a is related to cancer metastasis and is likely
to regulate these three functions through its regulated
PIN.
PAI-1, ITGB8, VAV2 and ITGA5 Are Oncogenes and Direct
Targets of MiR-148a
Four target genes of miR-148a were identified to be up-
regulated within its regulated PIN, including PAI-1 (a coa-
gulation factor), ITGB8 (an adhesion factor), VAV2 and
ITGA5 (involved in the integrin-mediated signaling path-
way). To further explore whether miR-148a affected can-
cer metastasis through its regulated PIN, a luciferase
reporter assay was performed to analyze the relationship
between miR-148a and these target genes. miR-148a over-
expression significantly reduced the expression levels of
these target genes, while their expression levels were sig-
nificantly elevated in anti-miR-148a inhibitor-transfected
tumor cells (t-test, P < 0.05, Figure 3A). We carried out
luciferase assay for site mutant to further ensure the corre-
lations between miR-148a and these four genes (Addi-
tional file 1, Figure S3). We constructed each putative
miR-148a target sites or its site mutation in sequences cor-
responded to seed sequence of miR-148a into a pMIR-
REPORT luciferase expression vector (Additional file 1,
Figure S3A) and analyzed reporter assays (Additional file
1, Figure S3B-S3E). Our results showed that the repres-
sions by miR-148a in these four genes were completely
abolished. These results suggest that these four genes are
direct targets of miR-148a. These observations suggest
that miR-148a plays a significant role in affecting the bio-
logical functions of gastric cancer cells by regulating the
expression of target genes within its regulated PIN.
In addition to being markers for the detection and
prognosis of many types of cancers [26-35], these four
g e n e sh a v ep r e v i o u s l yb e e nr e p o r t e dt ob ei m p l i c a t e di n
the promotion of cell invasion, migration, adhesion,
growth and angiogenesis, which suggests a possible role
for these genes in the regulation of tumor oncogenesis
and progression. To determine whether these genes
played a role in the oncogenesis of gastric cancer, their
expression levels in tumor tissues were measured by
immunoblotting. All four genes showed higher expres-
sion levels in tumor tissues compared with normal tissues
(Additional file 1, Figure S4), indicating that they might
have potential oncogenic functions and were likely to be
key downstream effectors of miR-148a in this network.
The Correlation Between miR-148a and
Clinicopathological Factors
To evaluate the clinical significance of miR-148a in gastric
cancer, the relationship between miR-148a expression
Figure 3 The relationship between miR-148a and PAI-1 (P), VAV2 (V), ITGB8 (I-8) and ITGA5 (I-5). (A) White and light gray bars represent
miR-148a precursor and inhibitor, respectively. Black and dark gray represent precursor and inhibitor negative controls, respectively. Over-
expressed miR-148a reduces invasion (B), migration (C) and adhesion (D) of tumor cells. Invasive, migratory and adhesive activities of tumor cells
were measured after transfection for 48hr with miR-148a precursor (light gray bar) and inhibitor-treated (dark gray bar) AGS, SC-M1 and MKN-45
cell lines. Precursor (white bar) and inhibitor (black bar) negative controls were used (t-test, *P < 0.05; **P < 0.01; ***P < 0.001).
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analyzed (see Methods in Additional file 1). Clinical ana-
lyses revealed that high expression levels of miR-148a sig-
nificantly correlated with a reduction in distant metastasis
(t-test, P = 0.043), organ invasion (t-test, P = 0.013) and
peritoneal invasion (t-test, P = 0.04) (Table 1). The rela-
tionship between miR-148a levels and all clinical factors
was shown in Additional file 1, Table S7. These results
suggest that miR-148a reduces the aggressiveness of gas-
tric cancer. Interestingly, our findings revealed that several
functions, including migration (integrin-mediated signal-
ing pathway) and adhesion, were identified within the
miR-148a-regulated PIN and were also associated with an
aggressive tumor phenotype. This indicates that miR-148a
likely plays an important role in regulating the malignant
progression of tumor cells.
MiR-148a Inhibits Cell Invasion, Migration, Adhesion and
Growth
In vitro invasion assays were performed to examine
whether miR-148a suppressed more aggressive forms of
tumors. Human gastric cancer AGS, SC-M1 and MKN-
45 cell lines were transfected with a miR-148a precursor
or an anti-miR-148a inhibitor. The results showed that
over-expression of miR-148a in these cell lines signifi-
cantly reduced tumor cell invasion, while anti-miR-148a-
treated tumor cells showed elevated tumor cell invasion
(Figure 3B). To determine whether miR-148a over-
expression also affected tumor progression, migration,
adhesion and proliferation assays were performed on
miR-148a-transfected tumor cells. Our findings indicated
that over-expressed miR-148a significantly reduced
tumor cell migration and adhesion, while anti-miR-148a-
treated tumor cells showed significantly elevated migra-
tory and adhesive abilities (Figure 3C and 3D). Addition-
ally, tumor cell growth was observed to be reduced in
response to miR-148a over-expression (Figure 4A and
4C), but elevated in response to anti-miR-148a inhibitor
treatment (Figure 4B and 4D). Taken together, these
observations indicate that miR-148a can inhibit cell inva-
sion, migration, adhesion and growth, thereby acting as a
potent regulator of tumor suppression.
Discussion
MiRNAs are known to function as gene silencers and
their expression profiles have been reported to be nega-
tively correlated with those of their target genes [25]. In
particular, up-regulated target genes were found to be
specific targets of down-regulated miRNAs in gastric
cancer. In order to reveal the possible roles that these
miRNAs play in gastric cancer, the predicted target genes
of miRNAs were analyzed within the human PIN and it
was shown that a stronger functional correlation existed
for miRNA targets that were linked to specific PPI part-
ners than for miRNA targets alone. Thus, this method
provides us to understand the biological functions of
miRNAs.
To find out the miRNA-regulated PINs in gastric cancer,
the expression profiles of miRNAs were integrated and
analyzed within the human PIN. Twenty three down-regu-
lated miRNA-regulated PINs were identified based on
their up-regulated target genes in gastric cancer. Among
these, sixteen PINs were activated. The results suggest
that repressing these miRNAs in gastric cancer can acti-
vate their regulated PINs. This may be due to miRNA-
mediated regulation of pivot genes, such as hubs [22], or
differentially expressed genes in the biological networks.
Therefore, we suggest that these 16 down-regulated miR-
NAs act as oncomirs and function as tumor suppressors.
Additionally, these 16 oncomirs were associated with
increased tumor suppression potential and increased sur-
vival rates compared with the 7 remaining down-regulated
miRNAs, suggesting that these oncomirs can be effective
markers for the diagnosis and prognosis of gastric cancer.
Among 16 down-regulated miRNAs, we found that the
miR-148a is down-regulated in gastric cancer and its
r e g u l a t e dP I Nw a sa s s o c i a t e dw i t ht u m o rm e t a s t a s i s -
related functions, such as integrin-mediated signaling,
cell-matrix adhesion, wound healing and blood coagula-
tion. These findings were validated by over-expressing
miR-148a in AGS, SC-M1 and MKN-45 gastric cancer
cell lines. While miR-148a over-expression led to a signif-
icant reduction in the invasive, migratory, adhesiveness
and growth properties of gastric cancer cells, miR-148a
inhibitor-treated tumor cells enhanced these effects.
Lujambio et al. found miR-148a inhibited metastasis for-
mation in xenograft models [36] and Chen et al. showed
that expression level of miR-148a in human gastric can-
cer was significantly lower than that in their matched
nontumor adjacent tissues [37]. These results support
our findings, miR-148a regulates malignant progression
in gastric cancer. Additionally, patients with high miR-
148a expression levels exhibited a significantly better
Table 1 The relationship between miR-148a expression
levels and clinical factors
No. of Patients % Mean (2-ΔΔCt) p-value
Distant metastasis
a 0.043*
Negative 58 94 0.549
Positive 4 6 0.238
Organ invasion
a 0.013*
Negative 27 44 0.630
Positive 35 56 0.415
Peritoneal invasion
a 0.040*
Negative 17 27 0.676
Positive 45 73 0.467
T: tumor; N: normal.
a t-test analysis.
b One-way ANOVA analysis. *P < 0.05.
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suggesting that miR-148a might function as a tumor sup-
pressor and could potentially serve as a diagnostic and
prognostic marker for gastric cancer.
We next ascertained whether miR-148a-mediated
down-regulation of PAI-1, VAV2, ITGA5, and ITGB8
expression resulted in the inhibition of malignant pro-
gression of tumor cells. These genes were identified as
up-regulated targets of miR-148a within its regulated
PIN and have been reported to have a high oncogenic
potential and are associated with aggressive tumor cell
phenotypes [26-33]. Herein, we showed that their expres-
sion levels were reduced in response to miR-148a over-
expression but elevated in response to anti-miR-148a
inhibitor treatment. Overall, these results suggest that
miR-148a influences the tumor progression-related biolo-
gical functions of cancer cells by regulating a small subset
of cancer-relevant genes within its regulated PIN.
Conclusions
In conclusion, a novel integrative network-based
approach was used to demonstrate the dynamic and
conditional nature of miRNA-regulated gene expression
and to discover the potential functions of these miRNAs
in gastric cancer. Furthermore, this approach facilitated
the identification of 16 activated oncomir-regulated
PINs which might be used as possible diagnostic and
prognostic markers of gastric cancer. In particular, miR-
148a was identified as a potential prognostic marker in
gastric cancer patients, with the ability to function as a
tumor suppressor through its regulated PIN. This study
not only provides an insight into the miRNA-regulated
PINs that are involved in the pathogenesis of gastric
cancer; it also shows that a network-based approach can
be used to identify novel diagnostic and prognostic mar-
kers of disease.
Methods
Expression Profiles of MiRNAs and mRNAs
The mRNA expression profiles of gastric cancer were
retrieved from Gene Expression Omnibus (GEO), acces-
sion number GSE13911 [38]. The miRNA expression
profiles were obtained from 22 paired tumor and non-
tumor specimens of gastric cancer patients who under-
went curative gastrectomy at National Taiwan University
Hospital (Taipei, Taiwan) between 2001 and 2006. Gas-
tric cancer and normal tissues from these patients were
collected at the National Taiwan University Hospital
after receiving patient written informed consent. The
protocol was approved by the local ethics committees,
National Taiwan University Hospital. We have sub-
mitted the miRNA microarray data to the GEO database
and the series record is GSE28700. All the human tissue
samples have been approved and human subject
Figure 4 Over-expressed miR-148a reduces cells growth. Cell growth was monitored in real-time using the xCELLigence system. (A, B) AGS
and (C, D) SC-M1 tumor cells were transfected with either miR-148a precursor or inhibitor and compared to their respective negative controls.
The results indicated that miR-148a reduced tumor cell growth (t-test, P = 0.23, A and P < 0.001, C), while miR-148a inhibitor-transfected tumor
cells showed increased cell growth (t-test, P < 0.001, B and P < 0.001, D). Black and gray solid lines represent miR-148a precursor and inhibitor,
respectively. Dashed lines represent their negative controls. The p-value was calculated using a paired t-test.
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Review Board (IRB, 9261700703). The characteristics of
these tissue specimens are described in Methods in
Additional file 1.
MiRNA-regulated PIN Identification and Analysis
The procedure for miRNA-regulated PIN identification
and analysis is illustrated in Figure 1. For identifying the
miRNA-regulated PINs, significantly differentially
expressed miRNAs and genes were determined by Sig-
nificance Analysis of Microarrays (SAM) [39] (delta of 5
and fold change of 2), implemented in MultiExperiment
Viewer (MeV) v4.5.1 [40]. As we applied this cutoff, we
could control the false discovery rate was less than
0.00001% (evaluated by SAM). Finally, only 23 signifi-
cantly down-regulated miRNAs and no significantly up-
regulated miRNAs were found. The regulated network
of each miRNA consists of its significantly up/down-
regulated target genes and their interacting partners in
the human PIN. The putative target genes of miRNAs
were obtained from TargetScan 5.1 [41], and the human
PIN was from Human Protein Reference Database
(HPRD) [42]. The enrichment of co-expressed PPIs
(CePPIs) involved in the network was used to evaluate
the activation state of miRNA-regulated PINs in tumor
and normal tissues (see Methods in Additional File 1).
MicroRNA-regulated biological functions were predicted
by functional enrichment analyses of their regulated
PINs (see Methods in Additional File 1).
Cell Culture and Authentication of Cell Lines
Human gastric cancer AGS, SC-M1 and MKN-45 cells
were obtained from the cell line databank in National
Taiwan University Hospital in 2008 and have been
tested and authenticated in our laboratory on a monthly
basis. These cells were last tested by morphology check
using microscope and mycoplasma detection using
Hoechst 33258 in March 2010. These cells were main-
tained in RPMI-1640 medium supplemented with 10%
fetal bovine serum (FBS; Invitrogen, Carlsbad, California,
U.S.A) and cultured at 37°C in an atmosphere of 5%
CO2.
qRT-PCR for MiRNA Expression
Total RNA from 62 paired tumor and normal tissues
was obtained using Trizol (Invitrogen) and the mirVana
miRNA isolation kit (Applied Biosystems, California, U.
S.A.) for miRNA detection.
Invasion Assays Using Boyden Chamber Assays
Cells were transfected with a miR-148a precursor and a
miR-148a inhibitor. After 24 hr, invasion assays were
performed with modified Boyden chambers containing
filter inserts (pore size, 8 μm) coated with Matrigel (35
μg, BD Biosciences) based on previously described
methods [43].
Wound Healing Assay
Cell monolayers were wounded after transfection for 48
hr by scratching with a 200 μl pipette tip. Debris was
removed by washing and the scratched cells were incu-
bated for 24 hr. Distances between wound edges were
measured at five different locations under × 20 magnifi-
cation by a microscope and analyzed using Metamorph
version 7.0 software.
Cell Adhesion Assay
Adhesion assays were performed using Matrigel coated
96-well plates that were incubated at 37°C for 1 hr.
Details are described in Methods in Additional File 1.
Cell Proliferation Assay
Cell growth was measured in real-time using the xCEL-
Ligence system (Roche Applied Science and ACEA Bios-
ciences). 7.5 × 10
3 cells were seeded in each well of an
E-plate 16 (Roche Applied Science and ACEA Bios-
ciences) and incubated at 37°C for 48 hr. After incuba-
tion, cells were transfected with a miR-148a precursor
and inhibitor and the growth of living cells were moni-
tored in real-time.
Additional information regarding details of individual
experimental procedures can be found in the Additional
files submitted along with the main manuscript.
Additional material
Additional file 1: figures, tables, and methods. This file contains
Figures S1-S9, Tables S1-S7. It includes the analyses of clinical data of
oncomirs, enriched functions of oncomir-regulated PIN, the expression of
miR-148a targets in tumor tissues, the relationship between miR-148a
and clinical factors, and the detailed methods.
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